Kalaris Therapeutics, Inc. - KLRS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$73.3M
QoQ value delta ($000)
-$57K (-0.08%)
Implied price effect (QoQ)
-0.04%
Shares
Total shares
18,024,002
QoQ shares delta
-6,979 (-0.04%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (KLRS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Samsara BioCapital, LLC 52,426 12,881,175 4.31%
RTW INVESTMENTS, LP 5,291 1,300,000 0.05%
Alyeska Investment Group, L.P. 2,330 572,687 0.01%
Siren, L.L.C. 1,773 435,798 0.04%
VANGUARD CAPITAL MANAGEMENT LLC 1,622 398,712 0.0%
Ikarian Capital, LLC 1,465 360,000 0.16%
UBS Group AG 1,066 262,131 0.0%
RENAISSANCE TECHNOLOGIES LLC 607 149,351 0.0%
MARSHALL WACE, LLP 566 139,201 0.0%
GEODE CAPITAL MANAGEMENT, LLC 464 114,037 0.0%
Woodline Partners LP 407 100,000 0.0%
ADAR1 Capital Management, LLC 407 100,000 0.02%
WHI TRUST Co LLC 396 97,493 0.26%
RAYMOND JAMES FINANCIAL INC 395 97,164 0.0%
CITADEL ADVISORS LLC 389 95,772 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 375 92,261 0.0%
Verdad Advisers, LP 326 80,297 0.31%
MORGAN STANLEY 294 72,326 0.0%
VANGUARD FIDUCIARY TRUST CO 269 66,179 0.0%
BlackRock, Inc. 221 54,442 0.0%
Belpointe Asset Management LLC 162 40,000 0.01%
Fortis Capital Advisors, LLC 162 40,000 0.02%
Pale Fire Capital SE 161 39,626 0.01%
Squarepoint Ops LLC 157 38,775 0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132 32,500 0.0%